ICDM 2023

S2 Basic research 1 Islet biology Chair(s): In-Kyu Lee, Miriam Cnop
Friday 20 October, 09:00~10:40
Room 2 (3F)

The Islets of Langerhans, commonly known as "islets," are small clusters of cells within the pancreas. They play a critical role in maintaining glucose homeostasis. This session consists of a carefully chosen collection of lectures that aim to clarify the obscure mechanisms behind the function of islets - presenting new perspectives on RNA processing, autophagy modulation, endoplasmic reticulum stress, and ciliary control.

S2-1 Lori Sussel University of Colorado, USA: RNA processing: novel mechanism modulating islet beta cell secretion

S2-2 Hye Seung Jung Seoul National University, Korea: Down-regulation of PERK in human islets for diabetes treatment

S2-3 Jaemin Lee DGIST, Korea: ER stress and its associated signaling modulate incretin receptor signaling

S2-4 Jing Hughes Washington University, USA: Ciliary control of islet function

S6 Translational research 1 Interorgan crosstalk for homeostasis Chair(s): Young-Bum Kim, Minho Shong
Friday 20 October, 16:00~17:40
Room 2 (3F)

Our body employs both humoral and neuronal systems to facilitate communication between organs, playing a pivotal role in maintaining intricate homeostasis. This session brings together four esteemed experts, each poised to illuminate distinct facets of this intricate interplay. Attendees are invited to embark on a journey of discovery, delving into the novel mechanisms underlying interorgan crosstalk axis modulation and its consequential impact on glucose, lipid, and energy metabolism homeostasis.

S6-1 Jong-Woo Sohn KAIST, Korea: Melanocortin regulation of autonomic nervous system

S6-2 Minho Shong KAIST, Korea: The GDF15-GFRAL axis controls systemic homeostasis in wasting syndrome

S6-3 Toshiyasu Sasaoka University of Toyama, Japan: Prevention of diabetes by metabolic adaptation of glucose and lipid utilization via activation of wakefulness and olfactory system

S6-4 Jihyun Kim Yonsei University, Korea: Gastrointestinal microbiome homeostasis in health, disease, and aging

S9 Basic research 2 Puzzling the last piece of liver diseases Chair(s): Jongsoon Lee, Hail Kim
Saturday 21 October, 09:00~10:40
Room 2 (3F)

The liver is a metabolic hub, contributing to metabolic diseases. Although both nonalcoholic and alcoholic fatty liver diseases have been extensively investigated, there are still several missing pieces. For instance, the evolution of NAFLD into hepatocellular carcinoma remains a puzzle. Similarly, is there a sex disparity in NAFLD? Is there a simple method to predict patients with NASH? This session will feature four presenters who are prepared to clarify these questions.

S9-1 Utpal Pajvani Columbia University, USA: Mechanisms of NASH-induced HCC

S9-2 Sang Geon Kim Dongguk University, Korea: G13 axis in the network of liver and muscle energy metabolism

S9-3 Youngmi Jung Pusan National University, Korea: Sex disparity in progression of nonalcoholic fatty liver disease

S9-4 Dongryeol Ryu GIST, Korea: Machine learning-driven discovery of a novel diagnostic index for NASH

S13 Translational research 2 New paradigms of cancer metabolism Chair(s): Kwan Woo Lee, Bong-Soo Cha
Saturday 21 October, 13:00~14:40
Room 2 (3F)

Metabolic derangement and mitochondrial dysfunction are a hallmark of tumor pathogenesis. In this session, four renowned speakers will provide groundbreaking insights into the altered metabolic pathways driving cancer growth, proliferation, and survival. Uncovering intricate interplay of oncogenes, tumor suppressors, and metabolic enzymes would provide innovative therapeutic approaches to target metabolic vulnerabilities in cancer cells. Stay at the forefront of cutting-edge research reshaping our understanding of cancer metabolism and its potential implications in cancer treatment.

S13-1 Sunghyouk Park Seoul National University, Korea: Non-bioenergetic ether lipid synthesis by mitochondrial GPD2 promotes tumor progression

S13-2 Keun-Gyu Park Kyungpook National University, Korea: Glutamine metabolism in tumor immune microenvironment

S13-3 Jungwhan Kim The University of Oklahoma, USA: Targeting hyperglycemia and insulin signaling for cancer therapy

S13-4 Soo-Youl Kim New Cancer Cure-Bio Co., Korea: Paradigm shift in cancer catabolism: from glucose-centric to fatty acid-centric

	사전등록 (~2023년 9월 15일까지)		현장등록 (2023년 10월 19일~21일)
	KDA회원	비회원	KDA회원	비회원
전문의(개원의, 교수, 봉직의, 전임의 포함)	₩280,000	₩350,000	₩370,000	₩450,000
전공의, 간호사, 영양사, 사회복지사, 약사, 연구원, 운동처방사 및 기타 (군의관 및 공중보건의 포함)	₩180,000	₩230,000	₩250,000	₩270,000
저녁 식사	₩30,000

Program details

평점안내 (For Korean)